Literature DB >> 14583612

Crystal structure of the homolog of the oncoprotein gankyrin, an interactor of Rb and CDK4/6.

Balasundaram Padmanabhan1, Naruhiko Adachi, Kazuhiro Kataoka, Masami Horikoshi.   

Abstract

The oncoprotein gankyrin plays a central role in tumorigenesis and cell proliferation. Gankyrin interacts with the retinoblastoma tumor suppressor (Rb) and cyclin-dependent kinase 4/6 (CDK4/6), increases phosphorylation at specific residues of Rb by CDK4/6 in vivo, and promotes tumorigenesis. The phosphorylation of Rb by CDK4/6 leads to the deregulation of the cell cycle during G1/S transition. Although how phosphorylation occurs on Rb has been studied extensively, the mechanism of site-specific phosphorylation of Rb remains unclear due to a lack of information on the structural arrangement of Rb and CDK4/6. Here, we have determined and refined to 2.3-A resolution the crystal structure of a gankyrin homolog, the non-ATPase subunit 6 (Nas6p) of the proteasome from yeast. The crystal structure reveals that Nas6p contains seven ankyrin repeats. The number of the repeats is different from that predicted from the primary structure. Nas6p also possesses an unusual curved structure with two acidic regions at the N- and C-terminal regions separated by one basic region, suggesting that it has at least two functional surfaces. The tertiary structure of Nas6p, together with the previous biochemical studies, indicates that the CDK4/6 and Rb binding surfaces of gankyrin are located at the N- and C-terminal regions, respectively, and face the same side of gankyrin. These observations suggest that gankyrin brings Rb and CDK4/6 together through gankyrin-Rb and gankyrin-CDK4/6 interactions and determines the relative positioning of the substrate (Rb) and the enzyme (CDK4/6). Our findings provide mechanistic insight into site-specific phosphorylation of Rb caused by CDK4/6.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14583612     DOI: 10.1074/jbc.M310266200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Crystal structure of the human TRPV2 channel ankyrin repeat domain.

Authors:  Clare J McCleverty; Eric Koesema; Ardem Patapoutian; Scott A Lesley; Andreas Kreusch
Journal:  Protein Sci       Date:  2006-08-01       Impact factor: 6.725

2.  AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation.

Authors:  Ji-Ming Bao; Min-Yi He; Ya-Wei Liu; Yong-Jie Lu; Ying-Qia Hong; Hai-Hua Luo; Zhong-Lu Ren; Shan-Chao Zhao; Yong Jiang
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Purification, crystallization and preliminary X-ray diffraction analysis of the non-ATPase subunit Nas6 in complex with the ATPase subunit Rpt3 of the 26S proteasome from Saccharomyces cerevisiae.

Authors:  Yoshihiro Nakamura; Takashi Umehara; Akiko Tanaka; Masami Horikoshi; Balasundaram Padmanabhan; Shigeyuki Yokoyama
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-02-10

4.  Evaluation of a structural polymorphism in the ankyrin repeat and kinase domain containing 1 (ANKK1) gene and the activation of executive attention networks.

Authors:  John Fossella; Adam E Green; Jin Fan
Journal:  Cogn Affect Behav Neurosci       Date:  2006-03       Impact factor: 3.282

5.  Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16.

Authors:  Anjali Mahajan; Yi Guo; Chunhua Yuan; Christopher M Weghorst; Ming-Daw Tsai; Junan Li
Journal:  J Mol Biol       Date:  2007-08-22       Impact factor: 5.469

6.  Gankyrin Drives Malignant Transformation of Gastric Cancer and Alleviates Oxidative Stress via mTORC1 Activation.

Authors:  Bo Huang; Weiyang Cai; Qian Wang; Feng Liu; Ming Xu; Yanjie Zhang
Journal:  Oxid Med Cell Longev       Date:  2018-10-21       Impact factor: 6.543

7.  The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression.

Authors:  Hui Liu; Zhen Wu; Haibin Zhou; Wenjie Cai; Xinjun Li; Jing Hu; Lin Gao; Tingting Feng; Lin Wang; Xijia Peng; Mei Qi; Long Liu; Bo Han
Journal:  Neoplasia       Date:  2019-06-22       Impact factor: 5.715

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.